Literature DB >> 11123084

Clinical trials review: vasculitis.

D K Ledford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11123084     DOI： 10.1007/s11926-000-0034-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  22 in total

1.  Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.

Authors:  Y Levy; Y Sherer; J George; P Langevitz; A Ahmed; Y Bar-Dayan; F Fabbrizzi; J Terryberry; J Peter; Y Shoenfeld
Journal:  Int Arch Allergy Immunol       Date:  1999-07       Impact factor: 2.749

Review 2.  Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

Authors:  D R Jayne; N Rasmussen
Journal:  Mayo Clin Proc       Date:  1997-08       Impact factor: 7.616

Review 3.  Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.

Authors:  D R Schultz; E C Tozman
Journal:  Semin Arthritis Rheum       Date:  1995-12       Impact factor: 5.532

Review 4.  New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy.

Authors:  C M Lockwood
Journal:  Clin Exp Immunol       Date:  1996-05       Impact factor: 4.330

Review 5.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

6.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

7.  Intravenous immunoglobulin as sole therapy for systemic vasculitis.

Authors:  D R Jayne; C M Lockwood
Journal:  Br J Rheumatol       Date:  1996-11

8.  Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis.

Authors:  M Haubitz; K M Koch; R Brunkhorst
Journal:  Nephrol Dial Transplant       Date:  1998-08       Impact factor: 5.992

Review 9.  Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity.

Authors:  C A Langford; J H Klippel; J E Balow; S P James; M C Sneller
Journal:  Ann Intern Med       Date:  1998-07-01       Impact factor: 25.391

10.  The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

Authors:  G S Hoffman; R Y Leavitt; G S Kerr; A S Fauci
Journal:  Arthritis Rheum       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.